Rezivertinib

MedChem Express

Rezivertinib [1835667-12-3]

10

1835667-12-3

Research Use Only

99.43

C27H30N6O3

486.57

Rezivertinib (BPI-7711) is an orally active, highly selective and irreversible third-generation EGFR tyrosine kinase inhibitor (TKI). Rezivertinib exhibits high potency against the common activation EGFR and the resistance T790M mutations. Rezivertinib has excellent central nervous system (CNS) penetration and has antitumor activity [1] [2] .

C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1OCCN(C)C)=O

-20°C,2°C to 8°C

12352200